Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19. (Q35828213)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

title

Feasibility of pharmacy-initiated pharmacogenetic screening for CYP2D6 and CYP2C19 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Willem Assendelft

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

Henk-Jan Guchelaar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

author name string

J J Swen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

T van der Straaten

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

J A M Wessels

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

E E W Vlassak

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

publication date

8 October 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Clinical Pharmacology

14 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

volume

68

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

page(s)

363-370

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

Genomics and drug response

14 February 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Pharmacogenetics: from bench to byte--an update of guidelines

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Clinical assessment incorporating a personal genome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Spontaneous ADR reports as a trigger for pharmacogenetic research: a prospective observational study in the Netherlands

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Risk of adverse outcomes associated with concomitant use of clopidogrel and proton pump inhibitors following acute coronary syndrome

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

DNA microarray technology in the clinical environment: the AmpliChip CYP450 test for CYP2D6 and CYP2C19 genotyping

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Cytochrome p-450 polymorphisms and response to clopidogrel

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Quality and quantity of saliva DNA obtained from the self-administrated oragene method--a pilot study on the cohort of Swedish men

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Defining the opportunity for pharmacogenetic intervention in primary care

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Pharmacogenetics of antidepressants and antipsychotics: the contribution of allelic variations to the phenotype of drug response

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Potential role of pharmacogenomics in reducing adverse drug reactions: a systematic review

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Pharmacogenomics: translating functional genomics into rational therapeutics

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Cytochrome P450 2D6 variants in a Caucasian population: allele frequencies and phenotypic consequences

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3303061

Pharmacogenomics: "noninferiority" is sufficient for initial implementation

11 July 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1130-4

Prevalence and determinants of pharmacy shopping behaviour.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1130-4

Patients' and physicians' perspectives on pharmacogenetic testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1130-4

Reasons for non-response in observational pharmacogenetic research.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1130-4

The prevalence of CYP2D6 and CYP2C19 genotypes in a population of healthy Dutch volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00228-011-1130-4

Quantitative effect of CYP2D6 genotype and inhibitors on tamoxifen metabolism: implication for optimization of breast cancer treatment

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21984116

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pharmacogenetics: From Bench to Byte

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/21984116

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00228-011-1130-4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21984116%20AND%20SRC:MED&resulttype=core&format=json

14 February 2020

PubMed publication ID

21984116

1 reference